Neoplasms by Histologic Type  >>  Provenge (sipuleucel-T)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Provenge (sipuleucel-T) / Bausch Health
NCT01431391: Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Checkmark STAND trial data at ASCO 2015
May 2015 - May 2015: STAND trial data at ASCO 2015
Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark AUA 2015
More
Completed
2
68
US
sipuleucel-T, PROVENGE®, APC8015, leuprolide acetate, Eligard®
Dendreon
Prostatic Neoplasm, Prostate Cancer, Prostatic Adenocarcinoma
12/14
12/14

Download Options